Stomach Cancer Trial, Recruiting (NCT04214119)

Stomach Cancer Trial, Recruiting NCT04214119 Sponsor: Johns Hopkins University Condition: Stomach Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT04214119 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Stomach Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who are having a camera examination of the throat, stomach, and upper digestive tract at Johns Hopkins Hospital between January 2016 and December 2025
People who are older than 18 years of age
People who are able to swallow a capsule

Who may not be able to join:

People who have a cancer located outside the food pipe (esophagus), including cancers of the head, neck, or stomach
People who have had surgery to remove part or all of the food pipe (esophagus)
People who have previously had radiation treatment to the chest area
People who are 18 years of age or younger
People who have a stent (a small tube used to hold a passage open) placed in their food pipe
People who have a narrowing of the food pipe that would prevent a capsule from passing through

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 13 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Stephen Meltzer, M.D., Johns Hopkins University

Phone: 4105026071

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT04214119

Sponsor: Johns Hopkins University

Phase: Not Applicable

Status: Recruiting

Condition: Stomach Cancer

Trial contact: 4105026071

More information: https://clinicaltrials.gov/study/NCT04214119

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who are having a camera examination of the throat, stomach, and upper digestive tract at Johns Hopkins Hospital between January 2016 and December 2025
People who are older than 18 years of age
People who are able to swallow a capsule

Who may not be able to join:

People who have a cancer located outside the food pipe (esophagus), including cancers of the head, neck, or stomach
People who have had surgery to remove part or all of the food pipe (esophagus)
People who have previously had radiation treatment to the chest area
People who are 18 years of age or younger
People who have a stent (a small tube used to hold a passage open) placed in their food pipe
People who have a narrowing of the food pipe that would prevent a capsule from passing through

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 13 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Johns Hopkins University

Registry

ClinicalTrials.gov

Start date

12 January 2016

Est. completion

19 December 2028

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Difference in methylation of gene markers to discriminate Barrett's esophagus from non-pathological esophageal squamous and gastric cardia tissue.; Difference in methylation of gene markers to discriminate esophageal carcinoma from non-pathological esophageal squamous and gastric cardia tissue.; Difference in methylation of gene markers to discriminate gastric cancer from non-pathological esophageal squamous and gastric cardia tissue.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 13 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov